TELA BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.45 USD | +1.37% |
|
-6.32% | -32.78% |
| 04-15 | TELA Bio, Inc. Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR | CI |
| 03-22 | Piper Sandler Adjusts Price Target on TELA Bio to $12 From $15, Maintains Overweight Rating | MT |
Chart calendar TELA Bio, Inc.
a2df.Q7QYDA-SyEeydw4kxGfOjfwy0Ip_sJ7lQwn6kNkMa3I.DvhvOiLTgyj2AGlAkR2Z5qVxgdNL99KnDzGfyrRJKkYRxUlrWPX6M4cbPg~914fd215586aadc951852e46e7457c66
Upcoming events on TELA Bio, Inc.
Past events on TELA Bio, Inc.
| 2024-03-21 16:30 | Q4 2023 Earnings Call |
| 2024-03-21 07:00 | Q4 2023 Earnings Release |
| 2023-11-30 11:00 | Piper Sandler Healthcare Conference |
| 2023-11-09 16:30 | Q3 2023 Earnings Call |
| 2023-11-09 16:05 | Q3 2023 Earnings Release |
| 2023-09-21 09:30 | Emerging Growth Company Showcase |
| 2023-08-10 09:00 | Canaccord Genuity Growth Conference |
| 2023-08-09 16:30 | Q2 2023 Earnings Call |
| 2023-08-09 16:03 | Q2 2023 Earnings Release |
| 2023-06-07 12:30 | Jefferies Global Healthcare Conference |
| 2023-06-01 10:00 | Annual General Meeting |
| 2023-05-15 12:00 | JMP Securities Life Sciences Conference |
| 2023-05-11 16:30 | Q1 2023 Earnings Call |
| 2023-05-11 16:02 | Q1 2023 Earnings Release |
| 2023-03-28 | Society of American Gastrointestinal and Endoscopic Surgeon Conference |
| 2023-03-21 16:30 | Q4 2022 Earnings Call |
| 2023-03-21 16:01 | Q4 2022 Earnings Release |
| 2023-01-12 11:15 | JP Morgan Healthcare Conference |
| 2022-11-30 11:30 | Piper Sandler Healthcare Conference |
| 2022-11-17 13:30 | Canaccord Genuity CG MedTech, Diagnostics and Digital Health & Services Forum |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 15,4 14,8 4.54% | 18,2 18,1 0.69% | 29,5 29,0 1.45% | 41,4 43,0 -3.7% | 58,5 57,9 0.99% | 74,9 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | -22,7 -22,5 -1.04% | -25,3 -22,5 -12.39% | -33,8 -35,3 4.18% | -38,2 -37,7 -1.41% | -36,3 |
|
EBIT Million USD | Released Forecast Spread | -19,2 -19,6 2.23% | -25,3 -25,2 -0.34% | -29,5 -28,8 -2.25% | -39,0 -38,9 -0.23% | -44,1 -41,7 -5.62% | -42,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | -28,8 -28,7 -0.33% | -33,3 -31,2 -6.5% | -44,3 -44,7 0.82% | -46,7 -44,6 -4.61% | -46,8 |
|
Net income Million USD | Released Forecast Spread | 0,00 0,00 - | -28,8 -28,7 -0.33% | -33,3 -31,2 -6.5% | -44,3 -44,7 0.82% | -46,7 -44,6 -4.61% | -46,8 |
|
EPS USD | Released Forecast Spread | -1,97 -1,95 -0.82% | -2,23 -2,16 -3.24% | -2,30 -2,22 -3.6% | -2,72 -2,78 2.07% | -2,04 -1,96 -3.91% | -1,82 |
| Announcement Date | 27/03/20 | 24/03/21 | 21/03/22 | 21/03/23 | 22/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 8,37 7,97 5.09% | 8,23 7,95 3.5% | 10,4 10,1 2.78% | 11,2 10,9 2.71% | 11,6 13,2 -11.88% | 11,9 12,0 -0.41% | 14,5 14,4 0.64% | 15,1 16,2 -7.06% | 17,0 16,4 3.72% | 16,3 | 18,4 | 19,4 | 20,9 | 20,6 |
|
EBITDA Million USD | Released Forecast Spread | -6,62 -4,30 -53.79% | -8,79 -7,25 -21.26% | -8,59 -7,15 -20.13% | -9,13 -8,06 -13.33% | -8,19 -8,39 2.39% | -9,91 -8,92 -11.14% | -10,2 -10,0 -1.99% | -10,1 -10,7 6.37% | -8,02 -8,28 3.05% | -10,3 | -9,21 | -8,86 | -7,99 | |
|
EBIT Million USD | Released Forecast Spread | -7,65 -7,01 -9.26% | -9,84 -8,00 -23.04% | -10,2 -8,37 -22.32% | -9,49 -8,98 -5.63% | -9,44 -9,35 -0.95% | -11,3 -10,2 -10.61% | -10,4 -10,9 4.8% | -10,2 -11,0 7.22% | -12,3 -9,93 -23.65% | -12,2 | -10,9 | -10,3 | -9,45 | -10,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,62 -6,59 -30.83% | -10,9 -9,46 -14.77% | -12,7 -9,37 -35.98% | -10,7 -10,1 -5.78% | -9,98 -10,4 3.93% | -12,0 -11,2 -7.04% | -10,8 -11,4 5.14% | -11,0 -11,8 7.03% | -12,9 -10,9 -18.56% | -12,9 | -11,8 | -11,5 | -10,6 | |
|
Net income Million USD | Released Forecast Spread | -8,62 -6,59 -30.83% | -10,9 -9,46 -14.77% | -12,7 -9,37 -35.98% | -10,7 -10,1 -5.78% | -9,98 -10,4 3.93% | -12,0 -11,2 -7.04% | -10,8 -11,4 5.14% | -11,0 -11,8 7.03% | -12,9 -10,9 -18.56% | -12,9 | -11,8 | -11,5 | -10,6 | |
|
EPS USD | Released Forecast Spread | -0,59 -0,52 -14.56% | -0,75 -0,62 -21.95% | -0,88 -0,63 -39.68% | -0,64 -0,62 -2.81% | -0,52 -0,55 5.02% | -0,63 -0,59 -6.18% | -0,46 -0,51 9.21% | -0,45 -0,16 -175.52% | -0,53 -0,43 -22.31% | -0,52 | -0,49 | -0,45 | -0,38 | -0,26 |
| Announcement Date | 21/03/22 | 10/05/22 | 10/08/22 | 09/11/22 | 21/03/23 | 11/05/23 | 09/08/23 | 09/11/23 | 22/03/24 | - | - | - | - | - |
More events
Past sector events for TELA Bio, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TELA Stock
- Calendar TELA Bio, Inc.
